Literature DB >> 656820

Anticonvulsants and thyroid function.

P P Yeo, D Bates, J G Howe, W A Ratcliffe, C W Schardt, A Heath, D C Evered.   

Abstract

Serum total and free thyroid hormone concentrations were estimated in 42 patients with epilepsy taking anticonvulsants (phenytoin, phenobarbitone, and carbamazepine either singly or in combination). There was a significant reduction in total thyroxine (TT4), free thyroxine (FT4), and free triiodothyronine (FT3) in the treated group compared with controls. Free hormone concentrations were lower than total hormone concentrations, suggesting that increased clearance of thyroid hormones occurs in patients receiving anticonvulsants. Detailed analysis indicated that phenytoin had a significant depressant effect on TT4, FT4, FT3, and reverse T3 (rT3). Phenobarbitone and carbamazepine had no significant main effects, but there were significant interactions between phenytoin and carbamazepine for TT4 and FT4. phenobarbitone and carbamazepine for FT3, and phenytoin and phenobarbitone for rT3.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 656820      PMCID: PMC1605396          DOI: 10.1136/bmj.1.6127.1581

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  16 in total

1.  The radioimmunoassay of 3,3',5' - triiodothyronine (reverse T3) in unextracted human serum.

Authors:  W A Ratcliffe; J Marshall; J G Ratcliffe
Journal:  Clin Endocrinol (Oxf)       Date:  1976-11       Impact factor: 3.478

2.  Assessment of thyroid hormone assays.

Authors:  D C Evered; P A Vice; E Green; D Appleton
Journal:  J Clin Pathol       Date:  1976-12       Impact factor: 3.411

3.  Effect of 5,5'-diphenylhydantoin on the metabolism of L-thyroxine-131-I in the rat.

Authors:  D M Mendoza; E V Flock; C A Owen; J Paris
Journal:  Endocrinology       Date:  1966-07       Impact factor: 4.736

4.  Endocrine manifestations of diphenylhydantoin therapy.

Authors:  H Gharib; J M Munoz
Journal:  Metabolism       Date:  1974-06       Impact factor: 8.694

5.  Radioimmunoassay of triiodothyronine in unextracted human serum.

Authors:  R D Hesch; D Evered
Journal:  Br Med J       Date:  1973-03-17

6.  Serum protein binding of thyroxine and diphenylhydantoin.

Authors:  R W Lightfoot; C L Christian
Journal:  J Clin Endocrinol Metab       Date:  1966-03       Impact factor: 5.958

7.  Thyroxine, triiodothyronine, and thyrotropin in serum during long-term diphenylhydantoin therapy.

Authors:  K Liewendahl; H Majuri
Journal:  Scand J Clin Lab Invest       Date:  1976-03       Impact factor: 1.713

8.  Increased thyroxine turnover and thyroidal function after stimulation of hepatocellular binding of thyroxine by phenobarbital.

Authors:  J H Oppenheimer; G Bernstein; M I Surks
Journal:  J Clin Invest       Date:  1968-06       Impact factor: 14.808

9.  Radioimmunoassay of free thyroid hormone concentrations in the investigation of thyroid disease.

Authors:  P P Yeo; M Lewis; D C Evered
Journal:  Clin Endocrinol (Oxf)       Date:  1977-02       Impact factor: 3.478

10.  Studies on the thyroxine-diphenylhydantoin interaction: effect of 5,5'-diphenylhydantoin on the displacement of L-thyroxine from thyroxine-binding globulin (TBG).

Authors:  J H OPPENHEIMER; R R TAVERNETTI
Journal:  Endocrinology       Date:  1962-09       Impact factor: 4.736

View more
  11 in total

1.  Nuclear receptors CAR and PXR in the regulation of hepatic metabolism.

Authors:  E S Tien; M Negishi
Journal:  Xenobiotica       Date:  2006 Oct-Nov       Impact factor: 1.908

Review 2.  Alteration of thyroid hormone homeostasis by antiepileptic drugs in humans: involvement of glucuronosyltransferase induction.

Authors:  M Strolin Benedetti; R Whomsley; E Baltes; F Tonner
Journal:  Eur J Clin Pharmacol       Date:  2005-11-24       Impact factor: 2.953

3.  Changes in thyroid function tests induced by 2 month carbamazepine treatment in L-thyroxine-substituted hypothyroid children.

Authors:  F De Luca; T Arrigo; E Pandullo; M F Siracusano; S Benvenga; F Trimarchi
Journal:  Eur J Pediatr       Date:  1986-04       Impact factor: 3.183

4.  Endocrine function changes in young males during long-term antiepileptic therapy with phenobarbitone and carbamazepine.

Authors:  L Rozza; A Marcolla; G Ferrari
Journal:  Ital J Neurol Sci       Date:  1987-08

5.  Genetic differences in maternal behaviour patterns in mice administered phenobarbital during pregnancy.

Authors:  G Laviola; K Sedowofia; J Innes; R Clayton; A Manning
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

6.  Thyroid hormone concentrations in epileptic patients.

Authors:  J G Larkin; G J Macphee; G H Beastall; M J Brodie
Journal:  Eur J Clin Pharmacol       Date:  1989       Impact factor: 2.953

7.  Changes in circulating thyroid hormones during short-term hepatic enzyme induction with carbamazepine.

Authors:  J M Connell; W G Rapeport; S Gordon; M J Brodie
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

8.  Effect of barbital on the pituitary-thyroid axis.

Authors:  M Ching
Journal:  J Endocrinol Invest       Date:  1981 Oct-Dec       Impact factor: 4.256

9.  Thyroid disorders in the elderly. Difficulties in diagnosis and treatment.

Authors:  A J Campbell
Journal:  Drugs       Date:  1986-05       Impact factor: 9.546

10.  The effective evaluation of thyroid status in patients on phenytoin, carbamazepine or sodium valproate attending an epilepsy clinic.

Authors:  A A Connacher; D Q Borsey; M C Browning; D L Davidson; R T Jung
Journal:  Postgrad Med J       Date:  1987-10       Impact factor: 2.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.